Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 • 7,749 citations
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 • 5,137 citations
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 • 3,314 citations
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
2009 • 1,805 citations
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
2004 • 1,155 citations
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
2009 • 712 citations
The EML4‐ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild‐type EGFR and KRAS
2009 • 700 citations
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
2009 • 665 citations
Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non–Small-Cell Lung Cancer: Current Knowledge and Future Directions
2005 • 636 citations
Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
2008 • 480 citations
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
2009 • 441 citations
A Novel, Highly Sensitive Antibody Allows for the Routine Detection ofALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
2010 • 423 citations
Anaplastic lymphoma kinase: signalling in development and disease
2009 • 410 citations
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
2009 • 313 citations
EML4-ALK Fusion Lung Cancer: A Rare Acquired Event
2008 • 252 citations
Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non–small cell lung carcinomas
2009 • 177 citations
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines
2005 • 173 citations
Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC).
2010 • 138 citations
Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Intrapulmonary Spread
2009 • 110 citations
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study
2009 • 75 citations
Cited By (0)
No citing papers found in database